Sweden: Biotage recommends shareholders accept KKR’s SEK11.607bn public takeover offer
RWK Bidco, a company owned by KKR, has made a cash offer of SEK145 per share for Nasdaq Stockholm-listed biotechnology company Biotage.
The board has...
Poland: CVC Credit provides debt facilities to American Heart of Poland
CVC Credit, the dedicated credit arm of PE firm CVC, has provided debt facilities to American Heart of Poland (AHP), Poland’s largest privately operated...
Italy: Claris Ventures launches Biotech II – a new VC fund for Italian biotech
Early-stage biotech investors Claris Ventures, a VC firm based in Turin, has announced the first closing of Claris Biotech II, a venture capital fund...
Switzerland: Ypsomed to sell diabetes business to TecMed for up to CHF420m
TecMed has entered into an agreement to acquire the Ypsomed Diabetes Care business of SIX-listed Ypsomed for up to CHF420m (US$517m), including earn-out. TecMed...
Ireland: Investindustrial agrees acquisition of DCC’s healthcare division for £1.05bn
Healthco Investment (an independently managed investment subsidiary of funds managed and/or advised by Investindustrial Advisors) has agreed to acquire DCC Healthcare, the healthcare division...
Germany: Goodwin advises Gimv on financing of Unizell acquisition and Medi-Markt refinancing
The Private Equity/Finance team at the German operation of global law firm Goodwin advised Gimv on the financing of the acquisition of Unizell Medicare...
Spain: DomusVi sells Spanish mental health division to Neural
Spain-based European senior care, housing and services company DomusVi, is selling its Spanish mental health subsidiary, Mentalia Salud, to Neural, a Spain neurorehabilitation company...
UK: Juvenescence receives strategic investment from M42
UK-based Juvenescence, a clinical-stage AI-enabled biotech company developing novel medicines to extend healthy lifespan, has received a strategic investment from Abu Dhabi-based M42, a...
UK: Ansor closes Fund II at hard cap of £250m in oversubscribed fundraise
Ansor, a UK-based ground-up buy-and-build investor, has held the final close of its second fund, Ansor Fund II, at its hard cap of £250m...
France: Five Arrows secures €2bn in commitments for latest secondary opportunities fund
Five Arrows, the alternative assets arm of Rothschild & Co, has completed fundraising for Secondary Opportunities VI, its sixth fund focused on GP-led secondary investments,...
Advertisement
